Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations☆
References (115)
- et al.
On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorimetric method
Life Sci.
(1963) - et al.
Demonstration and mapping out of nigro-neostriatal dopamine neurons
Life Sci.
(1964) - et al.
The nigrostriatal pathway
A correlative study based on neuroanatomical and neurochemical criteria in the cat and the monkey
Exp. Neurol.
(1969) - et al.
Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor
J. neurol. Sci.
(1971) - et al.
Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra
Exp. Neurol.
(1969) - et al.
Electrophysiological analysis of reciprocal caudato-nigral relations
Brain Research
(1967) - et al.
The effects of ventromedial tegmental lesions on the biosynthesis of catecholamines in the striatum
Life Sci.
(1966) - et al.
Experimental midbrain lesions
Neurochemical comparison between the animal model and Parkinson's disease
Brain Research
(1971) Dopamine and its physiological significance in brain function
- et al.
Anatomical and chemical studies of a nigro-neostriatal projection in the cat
Brain Research
(1971)
Projections of the lentiform nucleus in the monkey
Brain Research
(1966)
Cholesterasic striatopallidal and striatonigral efferents in the cat and the monkey
Brain Research
(1970)
Effect of interrupting the hypothalamic nervous connection on the norepinephrine and serotonin content in the hypothalamus
Exp. Neurol.
(1969)
Effect of amine precursors on the concentration of striatal dopamine and serotonin in cats with and without unilateral brain stem lesions
Brain Research
(1967)
The effect of brain stem lesions on tyrosine and tryptopham hydroxylases in various structures of the telencephalon of the cat
Brain Research
(1969)
Effect of l-dopa on brain monoamines and their metabolites in Parkinson's disease
Life Sci.
(1971)
Distribution of catechol compounds in human brain
Biochim. biophys. Acta (Amst.)
(1959)
Striatonigral degeneration
Response to levodopa therapy with pathological and neurological correlation
J. neurol. Sci.
(1973)
Sur les relations entre la substance noire et le noyau caudé
J. Physiol. (Paris)
(1967)
The pathology of Parkinsonism
Ascending monoamine neurons to the telencephalon and diencephalon
Acta physiol. scand.
(1966)
Striatonigral degeneration
Clinical-pathological correlations and response to stereotaxic surgery
Arch. Neurol. (Chic.)
(1970)
Gliafaserfärbung nach Kanzler
Dtsch. Z. Nervenheilk.
(1956)
l-dopa therapy in Parkinson's disease
A critical review of nine years' experience
Canad. med. Ass. J.
(1969)
Les catécholamines dans la maladie de Parkinson
Distribution of homovanillic acid in the human brain
Nature (Lond)
(1964)
Herabgesetzte Konzentration der Homovanillinsäure im Gehirn von parkinsonkranken Menschen als Ausdruck der Störung des zentralen Dopaminstoffwechsels
Klin. Wschr.
(1965)
Brain amines in Huntington's chorea
Verteilung des 5-Hydroxytryptamins (Serotonin) im Gehirn des Menschen und sein Verhalten bei Patienten mit Parkinson-Syndrom
Klin. Wschr.
(1961)
Zur Biochemie des Parkinsonsyndroms des Menschen
Klin. Wschr.
(1963)
Occurrence and localization of catecholamines in the human brain
Acta physiol. scand.
(1961)
Occurrence and distribution of dopamine in brain and other tissues
Experientia (Basel)
(1959)
Failures in l-dopa therapy
Der l-Dioxyphenylalanin (=l-Dopa)- Effekt bei der Parkinson-Akinese
Wien. klin. Wschr.
(1961)
Der l-Dioxyphenylalanin (=l-Dopa)-effekt beim Parkinson-Syndrom des Menschen
Zur Pathogenese und Behandlung der Parkinson-Akinese
Arch. Psychiat. Nervenkr.
(1962)
Huntington's chorea
Nigrostriatal and nigrothalamic fibers in the Rhesus monkey
J. comp. Neurol.
(1972)
Caudate unit responses to nigral stimuli: evidence for a possible nigro-striatal pathway
Science
(1968)
Caudate nucleus neurons: correlation of the effects of substantia nigra stimulation with iontophoretic dopamine
J. Physiol. (Lond.)
(1970)
Modification of Parkinsonism
Chronic treatment with l-Dopa
New Engl. J. Med.
(1969)
Aromatic amino acids and modification of Parkinsonism
New Eng. J. Med.
(1967)
Evidence for the existence of monoamine-containing neurons in the central nervous system, Part 1 (Demonstration of monoamines in the cell bodies of brain stem neurons)
Acta physiol. scand.
(1964)
l-Dopa treatment in Parkinson's disease: effect on dopamine and related substances in discrete brain regions
Experientia (Basel)
(1971)
Cholinergic-anticholinergic antagonism in Parkinsonism
Arch. Neurol. (Chic.)
(1967)
Parkinsonism
Studies on Parkinson's disease including X-ray fluorescent spectroscopy of formalin fixed brain tissue
J. Neuropath. exp. Neurol.
(1968)
Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems
Klin. Wschr.
(1960)
Pathology of Parkinsonism
J. Neurosurg.
(1966)
Concentric hyalin intraneuronal inclusions of Lewy type in the brains of elderly persons (50 incidental cases)
Relationships to Parkinsonism
J. Amer. Geriat. Soc.
(1969)
Cited by (0)
- ☆
Part of this work was presented at the 8th International Congress of Neurology, Vienna, Sept. 5–10, 1965 (Proceedings, Vol. 4/1, Wiener Medizinische Akademie, Vienna, 1965, pp. 145–148.), and at the Scientific Session of the Medical Society of Vienna, Nov. 17, 1967 (Wien. klin. Wschr., 1967, 79:903).
Copyright © 1973 Published by Elsevier B.V.